comprehensive -WSS

comprehensive

author：fashion 2025-09-07 06:41:20 - browse：3

Christoph Lengauer stands for a portrait. -- biotech coverage from STAT — Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

“Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Pregnancy discrimination could be enabled by AI

WSS

STAT letters to the editor on burnt

Medical mystery: When an infection after surgery isn’t what it seems

Lifetime voting ban for felony convictions struck down in Mississippi

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Russian court extends detention of American musician

Spinal cord stimulation reduces pain in amputees, study finds

knowledge

comprehensive

focus

Medical leaders decry Supreme Court decision on affirmative action

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Hollywood unions extend contract negotiations for actors

FDA needs staff influx to meet gene therapy needs, Marks says

Apple is now the first public company to be valued at $3 trillion

The woman behind the Dana Farber

After affirmative action ruling, medical educators look to 'holistic review'

Pregnancy discrimination could be enabled by AI

Hollywood unions extend contract negotiations for actors

Pregnancy discrimination could be enabled by AI

leisure time

Congenital heart disease patients face new threat of heart failure

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Medical schools are missing the mark on artificial intelligence

Does Medicare's free annual wellness visit do any good?

Pharma needs to include young adults in clinical research

FDA needs staff influx to meet gene therapy needs, Marks says

hotspot

focus

hotspot

explore